Get the Stockscreener App
4.54
2.48%
0.11
Pre-market:
4.50
-0.04
-0.88%
Briacell Therapeutics Corp Stock (BCTX) Forecast
The Briacell Therapeutics Corp (BCTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.2396, representing a -6.62% decrease from the current price of $4.54. The highest analyst price target is $5.1026, and the lowest is $3.3766.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCTX Price Target
Average 5.2817
(+16.34% Upside)
Is Briacell Therapeutics Corp (BCTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.55 | Neutral |
| STOCH(9,6) | 80.97 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.0232 | Buy |
| ADX(14) | 8.7285 | Neutral |
| William %R | -7.7778 | Sell |
| CCI(14) | 142.30 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.192
Buy
|
4.294
Buy
|
| MA20 |
4.2375
Buy
|
4.2334
Buy
|
| MA50 |
4.1467
Buy
|
4.633
Sell
|
| MA100 |
6.1617
Sell
|
5.5327
Sell
|
| MA200 |
6.3571
Sell
|
6.1153
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, BCTX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on BCTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 57.55 indicates that BCTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 80.97 indicates that BCTX is oversold. This means that BCTX price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BCTX is oversold. This suggests that BCTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 8.7285 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 142.3 indicates that BCTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term BCTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Briacell Therapeutics Corp financial reports and earnings history, Briacell Therapeutics Corp (BCTX) stock could reach $5.1554 by 2030, $5.5479 by 2040 and $3.1923 by 2050. See the projected annual prices until 2050 of the Briacell Therapeutics Corp stock below:
- Briacell Therapeutics Corp (BCTX) is expected to reach an average price of $0.6354 in 2035, with a high prediction of $1.4111 and a low estimate of $0.0407. This indicates an $-86.00% rise from the last recorded price of $4.54.
- Briacell Therapeutics Corp (BCTX) stock is projected to chart a bullish course in 2040, with an average price target of $5.4479, representing an $20.00% surge from its current level. The forecast ranges from a conservative $2.8275 to a sky-high $5.5479.
- Our analysts predict Briacell Therapeutics Corp (BCTX) to jump -75.07% by 2045, soaring from $0.652 to an average price of $1.132, potentially reaching $1.6977. While $0.652 is the low estimate, the potential upside is significant.
- Briacell Therapeutics Corp (BCTX) stock is expected to climb by 2050, reaching an average of $3.5723, a $-21.32% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.1923 and $3.2709, respectively, highlighting the market's uncertainty.
Briacell Therapeutics Corp Stock (BCTX) Year by Year Forecast
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2026
The predicted value for Briacell Therapeutics Corp (BCTX) in 2026 is set at an average of $5.3904. Estimates vary from a peak of $7.4422 to a trough of $3.3387, indicating an +18.73% surge from the present price of $4.54.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2026 | $3.7066 | $3.3766 | $5.1026 | -18.36% |
| June, 2026 | $6.1547 | $3.3387 | $6.3347 | +35.57% |
| July, 2026 | $6.4948 | $5.7448 | $7.2248 | +43.06% |
| August, 2026 | $5.2529 | $5.2429 | $6.8668 | +15.70% |
| September, 2026 | $6.3431 | $5.195 | $6.891 | +39.72% |
| October, 2026 | $5.6512 | $5.4612 | $6.8151 | +24.48% |
| November, 2026 | $5.3293 | $4.8572 | $5.9732 | +17.38% |
| December, 2026 | $5.6094 | $4.8253 | $5.9674 | +23.55% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Briacell Therapeutics Corp (BCTX) is $3.7238, with a high forecast of $6.7776 and a low forecast of $0.67. This indicates an -17.98% decrease from the last price of $4.54.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.8675 | $5.1655 | $5.9134 | +29.24% |
| February, 2027 | $6.7156 | $5.6321 | $6.7556 | +47.92% |
| March, 2027 | $4.6157 | $4.5657 | $6.7776 | +1.67% |
| April, 2027 | $4.3438 | $3.9818 | $5.5577 | -4.32% |
| May, 2027 | $3.1469 | $2.8758 | $4.5858 | -30.68% |
| June, 2027 | $3.942 | $3.0939 | $4.802 | -13.17% |
| July, 2027 | $4.6201 | $2.9341 | $5.2001 | +1.76% |
| August, 2027 | $3.3582 | $3.0762 | $4.8421 | -26.03% |
| September, 2027 | $2.7083 | $2.2743 | $3.5923 | -40.34% |
| October, 2027 | $1.7764 | $1.4464 | $2.9104 | -60.87% |
| November, 2027 | $1.2845 | $1.2745 | $2.2905 | -71.71% |
| December, 2027 | $1.524 | $0.67 | $1.6366 | -66.43% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2028
In 2028, Briacell Therapeutics Corp (BCTX) is projected to reach an average price of $5.5277, with a high projection of $10.43 and a low estimate of $0.6273. This indicates an +21.76% rise from the last price of $4.54.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6002 | $0.7521 | $2.0181 | -64.75% |
| February, 2028 | $1.5064 | $0.6273 | $3.1583 | -66.82% |
| March, 2028 | $2.9867 | $0.6486 | $6.8367 | -34.21% |
| April, 2028 | $3.1829 | $2.8407 | $5.4248 | -29.89% |
| May, 2028 | $2.9531 | $2.1191 | $4.665 | -34.95% |
| June, 2028 | $4.2993 | $2.5172 | $4.3793 | -5.30% |
| July, 2028 | $5.7655 | $4.3034 | $6.4015 | +26.99% |
| August, 2028 | $6.1258 | $4.8317 | $7.4136 | +34.93% |
| September, 2028 | $7.992 | $5.0839 | $8.442 | +76.03% |
| October, 2028 | $7.1382 | $6.9041 | $10.43 | +57.23% |
| November, 2028 | $6.4484 | $5.0263 | $8.0921 | +42.04% |
| December, 2028 | $4.3146 | $3.4006 | $6.7065 | -4.96% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2029
The 2029 price forecast for Briacell Therapeutics Corp Stock (BCTX) is $6.1283 on average, with a high prediction of $10.13 and a low estimate of $2.1234. This represents an +34.98% increase from the previous price of $4.54.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.6448 | $4.1987 | $6.1827 | +24.34% |
| February, 2029 | $7.651 | $4.7029 | $7.781 | +68.53% |
| March, 2029 | $6.6572 | $6.1072 | $10.13 | +46.64% |
| April, 2029 | $3.0034 | $2.1234 | $6.8213 | -33.85% |
| May, 2029 | $4.2637 | $2.5125 | $4.3737 | -6.09% |
| June, 2029 | $4.1799 | $3.4718 | $4.8877 | -7.93% |
| July, 2029 | $4.6161 | $3.858 | $4.782 | +1.68% |
| August, 2029 | $5.9063 | $4.3642 | $5.9863 | +30.10% |
| September, 2029 | $4.0125 | $3.9525 | $6.5144 | -11.62% |
| October, 2029 | $3.6028 | $3.2128 | $4.9587 | -20.64% |
| November, 2029 | $3.829 | $3.4509 | $4.4649 | -15.66% |
| December, 2029 | $3.9052 | $3.3771 | $4.2052 | -13.98% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2030
Briacell Therapeutics Corp Stock (BCTX) is expected to reach an average price of $4.2157 in 2030, with a high forecast of $6.3497 and a low forecast of $2.0817. This signifies an -7.14% decrease from the last price of $4.54.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.8754 | $2.4473 | $5.1554 | +7.39% |
| February, 2030 | $5.3116 | $4.4109 | $6.0535 | +17.00% |
| March, 2030 | $5.3378 | $4.8697 | $6.3497 | +17.57% |
| April, 2030 | $5.214 | $4.3299 | $5.8659 | +14.85% |
| May, 2030 | $5.7342 | $5.078 | $6.0321 | +26.30% |
| June, 2030 | $4.1804 | $4.0164 | $5.8783 | -7.92% |
| July, 2030 | $4.4707 | $3.9907 | $5.0526 | -1.53% |
| August, 2030 | $4.7469 | $4.2496 | $5.1347 | +4.56% |
| September, 2030 | $5.3331 | $4.3409 | $5.5025 | +17.47% |
| October, 2030 | $4.8633 | $4.6333 | $5.9652 | +7.12% |
| November, 2030 | $4.1995 | $3.7614 | $5.1174 | -7.50% |
| December, 2030 | $2.6657 | $2.0817 | $4.503 | -41.28% |
1.57%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):